VYRIPHARM BIOPHARMACEUTICALS
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 Feb 2023)
What this means for you
This application is over — abandoned 27 Feb 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88639444
- Mark type
- Word mark
- Filed
- 02 Oct 2019
- Published for opposition
- 26 May 2020
- Abandoned
- 27 Feb 2023
- Attorney of record
- Tasha Snipes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical drugs for the treatment of neurological disorders, cancer oncology, diabetes, metabolic disease; pharmaceutical products for treatment of neurological disorders, cancer oncology, diabetes, metabolic disease; diagnostic preparations, namely, drugs for neurological disorders, cancer oncology, diabetes, metabolic disease for medical purposes; drug devices, namely, injectable intravenous and subcutaneous drug delivery devices filled with pharmaceutical drugs and drug preparations for neurological disorders, cancer oncology, diabetes, metabolic disease; drug delivery system comprising of patch and adhesive biodegradable membrane externally or internally for neurological disorders, cancer oncology, diabetes, metabolic disease
- Class 010 — Medical apparatus: Drug delivery systems
Owner
- Vyripharm Enterprises LLC, Houston, TX, US
- Vyripharm Enterprises LLC, Houston, TX, US
Prosecution history
- 27 Feb 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 27 Feb 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 25 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jun 2022 — SOU EXTENSION 4 GRANTED
- 23 Jun 2022 — SOU EXTENSION 4 FILED
- 23 Jun 2022 — SOU TEAS EXTENSION RECEIVED
- 20 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jan 2022 — SOU EXTENSION 3 GRANTED
- 18 Jan 2022 — SOU EXTENSION 3 FILED
- 18 Jan 2022 — SOU TEAS EXTENSION RECEIVED
- 21 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Jul 2021 — SOU EXTENSION 2 GRANTED
- 19 Jul 2021 — SOU EXTENSION 2 FILED
- 19 Jul 2021 — SOU TEAS EXTENSION RECEIVED
- 15 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED